Literature DB >> 3606566

Formation, characterization and detection of a ternary complex between S protein, thrombin and antithrombin III in serum.

K T Preissner, L Zwicker, G Müller-Berghaus.   

Abstract

S protein, a plasma glycoprotein with Mr 78,000, has been shown to interfere with the heparin-catalysed inhibition of thrombin by antithrombin III. This interaction was further evaluated in the present study. Native human blood was replaced by either radiolabelled antithrombin III or radiolabelled prothrombin in the reaction mixture, which was incubated at 37 degrees C. At various time intervals the serum formed from the incubated blood was withdrawn and analysed by crossed immunoelectrophoresis against anti-(S protein) serum in the second dimension. Increasing quantities of radioactivity originating both from antithrombin III and from thrombin were precipitated in a cathodal shoulder to the S protein peak. This observation indicated the formation of a ternary S protein-thrombin-antithrombin III (STAT) complex in serum. This complex could also be observed by the same technique after incubation of purified thrombin in the presence of antithrombin III and S protein. Complex-formation was independent of the presence of heparin and did not require Ca2+ ions. Owing to the association of S protein with the thrombin-antithrombin III (TAT) complex, the STAT complex assembled in vitro exhibited a higher Mr than the TAT complex as judged by polyacrylamide-gradient-gel electrophoresis in the absence of SDS. Both the serum-originated STAT complex and the STAT complex assembled from purified components sedimented faster than the single components and showed comparable apparent sedimentation coefficients in the range 11-14 S, corresponding to a mean Mr of 350,000. The STAT complex could be detected in serum at a dilution of 1:3200 by a sensitive immuno-radiometric assay employing affinity-purified IgG against S protein. These results indicate that S protein, in addition to its role as a heparin-neutralizing factor, becomes incorporated into the nascent TAT complex or can bind to preformed TAT complex during the clotting process.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3606566      PMCID: PMC1147820          DOI: 10.1042/bj2430105

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  46 in total

1.  A method for determining the sedimentation behavior of enzymes: application to protein mixtures.

Authors:  R G MARTIN; B N AMES
Journal:  J Biol Chem       Date:  1961-05       Impact factor: 5.157

2.  Neoantigenic expression in enzyme-inhibitor complexes. A means to demonstrate activation of enzyme systems.

Authors:  D Collen; F de Cock
Journal:  Biochim Biophys Acta       Date:  1978-07-07

3.  On the complex formation of antithrombin 3 with thrombin. Gelfiltration studies on human plasma and serum.

Authors:  B Binder
Journal:  Thromb Diath Haemorrh       Date:  1973-11

4.  The purification and mechanism of action of human antithrombin-heparin cofactor.

Authors:  R D Rosenberg; P S Damus
Journal:  J Biol Chem       Date:  1973-09-25       Impact factor: 5.157

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  The measurement of partial specific volumes and sedimentation coefficients by sucrose density centrifugation.

Authors:  R D O'Brien; C A Timpone; R E Gibson
Journal:  Anal Biochem       Date:  1978-06-01       Impact factor: 3.365

7.  The in vivo metabolism of antithrombin III and antithrombin III complexes.

Authors:  M A Shifman; S V Pizzo
Journal:  J Biol Chem       Date:  1982-03-25       Impact factor: 5.157

8.  The binding of low-affinity and high-affinity heparin to antithrombin. Fluorescence studies.

Authors:  B Nordenman; A Danielsson; I Björk
Journal:  Eur J Biochem       Date:  1978-09-15

9.  Heparin with two binding sites for antithrombin or platelet factor 4.

Authors:  R E Jordan; L V Favreau; E H Braswell; R D Rosenberg
Journal:  J Biol Chem       Date:  1982-01-10       Impact factor: 5.157

10.  The covalent nature of the human antithrombin III--thrombin bond.

Authors:  M O Longas; T H Finlay
Journal:  Biochem J       Date:  1980-09-01       Impact factor: 3.857

View more
  5 in total

1.  Specific binding of the human S protein (vitronectin) to streptococci, Staphylococcus aureus, and Escherichia coli.

Authors:  G S Chhatwal; K T Preissner; G Müller-Berghaus; H Blobel
Journal:  Infect Immun       Date:  1987-08       Impact factor: 3.441

Review 2.  Biochemical markers for the diagnosis of venous thromboembolism: the past, present and future.

Authors:  Giuseppe Lippi; Gianfranco Cervellin; Massimo Franchini; Emmanuel J Favaloro
Journal:  J Thromb Thrombolysis       Date:  2010-11       Impact factor: 2.300

3.  The cluster of basic amino acids in vitronectin contributes to its binding of plasminogen activator inhibitor-1: evidence from thrombin-, elastase- and plasmin-cleaved vitronectins and anti-peptide antibodies.

Authors:  Z Gechtman; A Belleli; S Lechpammer; S Shaltiel
Journal:  Biochem J       Date:  1997-07-15       Impact factor: 3.857

Review 4.  The role of vitronectin as multifunctional regulator in the hemostatic and immune systems.

Authors:  K T Preissner
Journal:  Blut       Date:  1989-11

5.  Vitronectin binds to the gonococcal adhesin OpaA through a glycosaminoglycan molecular bridge.

Authors:  T D Duensing; J P Putten
Journal:  Biochem J       Date:  1998-08-15       Impact factor: 3.857

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.